Cas:18398-80-6 2-oxopyran-3-carbonyl chloride manufacturer & supplier

We serve Chemical Name:2-oxopyran-3-carbonyl chloride CAS:18398-80-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-oxopyran-3-carbonyl chloride

Chemical Name:2-oxopyran-3-carbonyl chloride
CAS.NO:18398-80-6
Synonyms:2-pyrone-3-carboxylic acid chloride;2-oxo-2H-pyran-3-carbonyl chloride;2-pyrone-3-carbonyl chloride;2H-Pyran-3-carbonyl chloride,2-oxo
Molecular Formula:C6H3ClO3
Molecular Weight:158.53900
HS Code:2932209090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:47.28000
Exact Mass:157.97700
LogP:1.01880

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-pyrone-3-carboxylic acid chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2H-Pyran-3-carbonyl chloride,2-oxo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-pyrone-3-carboxylic acid chloride Use and application,2-pyrone-3-carbonyl chloride technical grade,usp/ep/jp grade.


Related News: The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. (S)-5-methyl-4-(2-amino-2-methoxycarbonyl-ethyl)-3-isoxazolecarboxylic acid ethyl ester manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 4-acetoxytetrahydrofuran-3-yl (2-chloro-4-fluoro-5-(5-methyl-1,3-dioxoisoindolin-2-yl)phenyl)-L-alaninate suppliers “The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added. L-Lys-pNa vendor & factory.